tirzepatide fda approval 2022 The long awaited twincretin was just approved on Friday for type 2 diabetes! π Marketed under the brand name Mounjaro, is the first dual GIP and GLP-1 receptor agonist. GIP Tirzepatide Wins FDA Approval for
Pay in 4 interest-free payments of $6.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 8 - Aug 13





























